A West Australian study will research an alternative pain treatment for endometriosis — which one in seven women are expected ...
Akeso, Inc. (9926.HK)  (Akeso or the Company) announced today that its proprietary first-in-class trispecific antibody, AK150 ...
Tetratherix launches precision medicine franchise via Tetramatrix; signs exclusive US$3m/year deal with Superpower Health for ...